Works matching Investigational therapies

Results: 1778
    1

    Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats.

    Published in:
    Veterinary & Comparative Oncology, 2021, v. 19, n. 2, p. 311, doi. 10.1111/vco.12677
    By:
    • LeBlanc, Amy K.;
    • Atherton, Matthew;
    • Bentley, R. Timothy;
    • Boudreau, C. Elizabeth;
    • Burton, Jenna H.;
    • Curran, Kaitlin M.;
    • Dow, Steven;
    • Giuffrida, Michelle A.;
    • Kellihan, Heidi B.;
    • Mason, Nicola J.;
    • Oblak, Michelle;
    • Selmic, Laura E.;
    • Selting, Kimberly A.;
    • Singh, Ameet;
    • Tjostheim, Sonja;
    • Vail, David M.;
    • Weishaar, Kristen M.;
    • Berger, Erika P.;
    • Rossmeisl, John H.;
    • Mazcko, Christina
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Four cases of investigational therapy with interleukin-11 against acute myocardial infarction.

    Published in:
    Heart & Vessels, 2016, v. 31, n. 9, p. 1574, doi. 10.1007/s00380-015-0788-4
    By:
    • Nakagawa, Masashi;
    • Owada, Yasuko;
    • Izumi, Yasukatsu;
    • Nonin, Shinichi;
    • Sugioka, Kenichi;
    • Nakatani, Daisaku;
    • Iwata, Shinichi;
    • Mizutani, Kazuki;
    • Nishimura, Satoshi;
    • Ito, Asahiro;
    • Fujita, Suwako;
    • Daimon, Takashi;
    • Sawa, Yoshiki;
    • Asakura, Masanori;
    • Maeda, Makiko;
    • Fujio, Yasushi;
    • Yoshiyama, Minoru
    Publication type:
    Article
    17

    Investigational Therapies and Patients' Autonomy.

    Published in:
    Canadian Journal of Bioethics / Revue canadienne de bioéthique, 2020, v. 3, n. 3, p. 115, doi. 10.7202/1073786ar
    By:
    • Papakonstantinou, Trisevgeni;
    • Kolettis, Theofilos M.
    Publication type:
    Article
    18

    Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    2025
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Correction Notice
    19

    First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1376551
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Article
    20

    First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1376551
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29

    The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 1, p. 115, doi. 10.1007/s11060-009-0058-3
    By:
    • Olson, Jeffrey;
    • Paleologos, Nina;
    • Gaspar, Laurie;
    • Robinson, Paula;
    • Morris, Rachel;
    • Ammirati, Mario;
    • Andrews, David;
    • Asher, Anthony;
    • Burri, Stuart;
    • Cobbs, Charles;
    • Kondziolka, Douglas;
    • Linskey, Mark;
    • Loeffler, Jay;
    • McDermott, Michael;
    • Mehta, Minesh;
    • Mikkelsen, Tom;
    • Patchell, Roy;
    • Ryken, Timothy;
    • Kalkanis, Steven
    Publication type:
    Article
    30
    31

    HBV and HDV: New Treatments on the Horizon.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4054, doi. 10.3390/jcm10184054
    By:
    • Zuccaro, Valentina;
    • Asperges, Erika;
    • Colaneri, Marta;
    • Marvulli, Lea Nadia;
    • Bruno, Raffaele
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Current status and research directions in acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01143-2
    By:
    • Kantarjian, Hagop;
    • Borthakur, Gautam;
    • Daver, Naval;
    • DiNardo, Courtney D.;
    • Issa, Ghayas;
    • Jabbour, Elias;
    • Kadia, Tapan;
    • Sasaki, Koji;
    • Short, Nicholas J.;
    • Yilmaz, Musa;
    • Ravandi, Farhad
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46

    Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 870, doi. 10.1093/jnci/djad046
    By:
    • Spencer, Kristen;
    • Pappas, Leontios;
    • Baiev, Islam;
    • Maurer, Jordan;
    • Bocobo, Andrea Grace;
    • Zhang, Karen;
    • Jain, Apurva;
    • Armas, Anaemy Danner De;
    • Reyes, Stephanie;
    • Le, Tri Minh;
    • Rahma, Osama E;
    • Stanton, Jennifer;
    • DeLeon, Thomas T;
    • Roth, Marc;
    • Peters, Mary Linton B;
    • Zhu, Andrew X;
    • Lennerz, Jochen K;
    • Iafrate, A John;
    • Boyhen, Kylie;
    • VanCott, Christine
    Publication type:
    Article
    47
    48

    Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.

    Published in:
    Annals of Gastroenterology, 2016, v. 29, n. 1, p. 18
    By:
    • Kountourakis, Panteleimon;
    • Souglakos, John;
    • Gouvas, Nikolaos;
    • Androulakis, Nikolaos;
    • Athanasiadis, Athanasios;
    • Boukovinas, Ioannis;
    • Christodoulou, Christos;
    • Chrysou, Evangelia;
    • Dervenis, Christos;
    • Emmanouilidis, Christos;
    • Georgiou, Panagiotis;
    • Karachaliou, Niki;
    • Katopodi, Ourania;
    • Makatsoris, Thomas;
    • Papakostas, Pavlos;
    • Pentheroudakis, Georgios;
    • Pilpilidis, Ioannis;
    • Sgouros, Joseph;
    • Tekkis, Paris;
    • Triantopoulou, Charina
    Publication type:
    Article
    49
    50